Login
← Go Back
Senores Pharmaceuticals
SENORES · Pharma > Pharmaceuticals & Drugs Listing date: Dec. 30, 2024
Stock Price vs Company Growth
1d
0.5%
1w
3.0%
1m
5.9%
3m
2.0%
all
0.7%
Created with Highcharts 8.2.2SalesProfitPriceDividendQtr SalesOperating CashflowLatest
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 562 0.5%
440
664
Company Overview
Sales
339 Cr
Growth: 0.0%
Profit after Tax
38.5 Cr
Growth: 35.6%
Small Cap
2,586 Cr
P/E: 36.3x
Industry P/E: 32.5x
Created with Highcharts 8.2.2HistoricalGrowthValuationAttractivenessProfitabilityIndustryOutlookPriceStability10
Fundamentals
Sales (Cr) ₹ 339
Growth 0.0%
EBITDA 21.0%
P/S 7.6x
Dividend 0.0%
P/E 36.3x
Book Value ₹ 10
PEG Ratio N/A
ROE 113.2%
P/B N/A
Shareholding Pattern
Increase    Decrease    No change
Company Profile Detailed
Senores Pharmaceuticals Limited was originally incorporated as ‘Senores Pharmaceuticals Private Limited’ under the Companies Act, 2013 through certificate of incorporation dated December 26, 2017, issued by the Registrar of Companies, Central Registration Centre.
Belongs to (6 Indices) view more
Investors (4)
jeshika....
sanjay.s...
renosen....
Followers (1)
varsha96